US survey finds increased support for "behind-the-counter" drugs

A study by a USA-based pharmaceutical marketing research firm, Leo J Shapiro & Associates (LJS), reveals that two-thirds of US citizens believe the Food and Drug Administration should make certain drugs obtainable without a prescription, but only after consultation with a pharmacist. With the federal agency currently exploring the public health benefit to consumers of such a "behind-the-counter" status of drugs (Marketletter November 26), the results of the study show a majority (67%) of consumers are attracted by the convenience and access to their medications BTC, even if insurers would not cover the cost. Respondents were interviewed in person by telephone during November in this study of 450 US households.

Obtaining BTC medications from a pharmacist would be more convenient than seeing a doctor, according to 62% of consumers. LJS also reported that two thirds of respondents agree that BTC would allow people without the benefit of health insurance to have access to medications they may need. Among households without health insurance this belief was even stronger, at 82%.